Anti-tuberculous therapy combined with systemic corticosteroids improves retinal sensitivity in patients with active presumed tuberculous choroiditis.
To investigate the efficacy of anti-tuberculous therapy and systemic corticosteroids in patients suffering from active presumed tuberculous choroiditis by the assessment of central retinal sensitivity and fixation characteristics. Six patients (six eyes) with active presumed tuberculous choroiditis were treated with anti-tuberculous therapy and systemic corticosteroids. Mean central retinal sensitivities and fixation stability and location were investigated with MP-1 microperimetry before and after treatment. After a mean follow-up of 11.33 ± 7.53 months (range 6-24 months), all eyes showed resolution of inflammation, with no recurrences, associated with a significant improvement in visual acuity (P = 0.003). At the baseline, mean central retinal sensitivities were 2.03 ± 2.46 dB (range 0.0-6.6 dB). Fixation was stable and predominantly central in three eyes, and unstable and predominantly eccentric in three eyes. After treatment at a mean of 9.33 ± 6.56 months (range 4-20 months), mean central retinal sensitivities improved to 9.65 ± 5.35 dB (range 2.4-15.2 dB) (P = 0.004) and fixation became predominantly central and stable in all eyes. Anti-tuberculous therapy combined with systemic corticosteroids improves central retinal sensitivity and fixation characteristics in patients with presumed tuberculous choroiditis.
Abu El-Asrar
Ahmed M
AM
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. abuasrar@ksu.edu.sa
Al-Mezaine
Hani S
HS
D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage*; D002833:Choroiditis / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012160:Retina / Q000503:physiopathology; D041623:Tomography, Optical Coherence; D014392:Tuberculosis, Ocular / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D058609:Visual Field Tests
D000995:Antitubercular Agents; D005938:Glucocorticoids
Curr Opin Ophthalmol. 2000 Dec;11(6):443-8
11141639
Retina. 2007 Jan;27(1):21-9
17218911
Medicine (Baltimore). 1984 Jan;63(1):25-55
6419006
Am J Ophthalmol. 2008 Nov;146(5):761-6
18718569
Arch Ophthalmol. 1998 Oct;116(10):1386-8
9790648
Int Ophthalmol. 2009 Apr;29(2):67-74
17486298
Surv Ophthalmol. 1993 Nov-Dec;38(3):229-56
8310395
Am J Ophthalmol. 2001 Dec;132(6):897-902
11730655
Surv Ophthalmol. 2004 Jan-Feb;49(1):78-89
14711441
Int Ophthalmol. 2008 Dec;28(6):413-23
18034214
Am J Ophthalmol. 2008 Nov;146(5):772-9
18708180
Ophthalmology. 2003 Sep;110(9):1744-9
13129872
Ophthalmology. 2002 Sep;109(9):1737-44
12208725
Br J Ophthalmol. 2007 Nov;91(11):1499-503
17504849
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1453-62
15790915
Ophthalmologe. 2006 Sep;103(9):791-7
16874536
Eye (Lond). 2006 Sep;20(9):1068-73
16215543
Semin Ophthalmol. 2004 Mar-Jun;19(1-2):55-61
15590535
Ophthalmology. 2002 May;109(5):851-7
11986087
J Fam Pract. 2006 Aug;55(8):718-20
16882448
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3044-51
16799051
Retina. 2009 Jun;29(6):757-67
19289982
Br J Ophthalmol. 2002 Nov;86(11):1248-51
12386081
Surv Ophthalmol. 2007 Nov-Dec;52(6):561-87
18029267
Eye (Lond). 1990;4 ( Pt 3):486-92
2209914
Arch Ophthalmol. 2006 Dec;124(12):1777-9
17159041
Retina. 2001;21(5):435-44
11642371